Dexamethasone plus supportive care versus supportive care for adhesive small bowel obstruction.
Official title: Comparison of Outcomes of Management of Bowel Obstruction
Run by University of Washington · NCT07084441 · Data updated 2026-11-12
This trial tests whether a short course of IV dexamethasone plus supportive care helps adults with adhesive small bowel obstruction recover without surgery compared with supportive care alone.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 550 (estimated) |
| Sponsor | University of Washington Academic / other |
| Locations | 4 sites (New York, New York and 3 other locations) |
| Status | Recruiting |
| Started | February 3, 2026 |
| Main results expected | June 2030 |
| Study ends | December 2030 |
| Registry record updated | May 7, 2026 |
| Trial ID | NCT07084441 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) presenting to participating centers with CT-confirmed adhesive small bowel obstruction deemed appropriate for non-operative management who can consent in English and complete follow-up.
✕Probably not a fit
Patients with signs of peritonitis or an urgent need for surgery, recent abdominal surgery within six weeks, allergy to dexamethasone, or SBO caused by hernia, mass, volvulus, or other non-adhesive causes are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a double-blind, patient-level randomized Phase 4 comparison of intravenous dexamethasone (given 2–3 times daily for 5–7 days) plus standard supportive care versus supportive care alone in adults with adhesion-related small bowel obstruction who do not require immediate operation. Eligible patients present to participating surgical services with CT-confirmed SBO and clinical features suggesting adhesions from prior abdominopelvic surgery, and must be able to provide informed consent in English. The primary outcome is resolution of obstruction with non-operative management without complication using a predefined minimal clinically important difference. The study is being conducted at University of Washington hospitals (Harborview and UW Medical Center - Northwest) and Columbia University Medical Center with required follow-up to confirm outcomes.
Why it matters
Potential benefit: If successful, the intervention could increase the chance of resolving adhesive SBO without surgery, shorten hospital stays, and reduce complications related to emergency operations.
How similar studies have gone: Prior randomized trials in malignant small bowel obstruction found that dexamethasone may help resolve obstruction, but randomized evidence specifically for adhesion-related SBO is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults ≥18 years of age recruited from UWMC * Patients presenting to surgical services through the Emergency Department, diagnosis of SBO, consulted by surgeon, and an urgent or emergency operation is deemed not necessary by surgeon. * Diagnosis of aSBO is established by; 1. CT findings consistent with diagnosis of SBO; and 2. signs and symptoms consistent with SBO; and 3. Adhesions from prior abdominopelvic surgery are the likely cause of SBO (absence of incarcerated hernia, internal hernia, masses, fistula, stricture, volvulus, acute episode of inflammatory bowel disease (IBD) flare, etc.). * Ability to provide written or electronic informed consent in English and answer teach-back questions Exclusion Criteria: * Signs and symptoms of peritonitis with emergency operation planned * Planned urgent operation within the next 12 hours * Allergy to dexamethasone * Surgery within prior 6 weeks * Unable or unwilling to return or be contacted for and/or complete research surveys * Currently incarcerated in a detention facility or in police custody (patients wearing a monitoring device can be enrolled) at baseline/screening * Individuals with latent infections who have an increased risk of infection.
Where it's running
-
Columbia University Medical Center
New York, New York, United States Recruiting -
Harborview Medical Center
Seattle, Washington, United States Recruiting -
UW Medical Center - Northwest
Seattle, Washington, United States Recruiting -
University of Washington Medical Center Montlake
Seattle, Washington, United States Recruiting
Study contacts
- Principal investigator: David Flum, MD MPH — University of Washington
- Study coordinator: Kelsey Pullar, MPH
- Email: kpullar@uw.edu
- Phone: 206.221.8247
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Optimizing treatment for adhesive small bowel obstruction
This study is testing whether using nasogastric tubes or water-soluble contrast can improve treatment for adults with adhesive small bowel obstruction and help them feel better.
-
Universal newborn hearing screening in Kenya using smartphone tests
This study tests whether smartphone hearing screening can help identify ear infections and hearing loss in infants, including those exposed to HIV, over 6 months.
-
Greek Connections Program to nudge Greek members toward alcohol-free social activities
This study tests whether increasing alcohol-free social events among fraternities and sororities can reduce heavy drinking and related problems in college students.
-
Spinal Stimulation During Walking to See If Spasticity Lessens in Cerebral Palsy
This study tests whether walking with non-invasive spinal stimulation reduces leg muscle tightness and improves walking in children and young adults with cerebral palsy.
-
KABAWIL: Reducing Stigma for Indigenous Men and Healers in Guatemala
A culturally tailored program called KABAWIL will be tried to see if it can reduce HIV-related and intersectional stigma and help Indigenous men and healers engage more with HIV prevention and care in Guatemala.
-
Uterine Lavage to Screen BRCA Carriers for Ovarian Cancer Risk
This study tests whether rinsing the uterus with saline and analyzing the collected cells can help detect early signs of ovarian cancer in women with BRCA mutations who are planning risk-reduction surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.